Abstract
Individuals from racial/ethnic minority backgrounds and women have not been proportionately represented in AIDS clinical trials (ACTs). There have been few intervention efforts to eliminate this health disparity. This paper reports on a brief behavioral intervention to increase rates of screening for ACTs in these groups. The study was exploratory and used a single-group pre/posttest design. A total of 580 persons living with HIV/AIDS (PLHA) were recruited (39% female; 56% African-American, 32% Latino/Hispanic). The intervention was efficacious: 25% attended screening. We identified the primary junctures where PLHA are lost in the screening process. Both group intervention sessions and an individual contact were associated with screening. Findings provide preliminary support for the intervention’s efficacy and the utility of combining group and individual intervention formats. Interventions of greater duration and intensity, and which address multiple levels of influence (e.g., social, structural), may be needed to increase screening rates further.
Similar content being viewed by others
References
Allison, P. D. (1999). Logistic regression using the SAS system: Theory and application. Cary, NC: SAS Institute.
Anderson, D. (2004). A guide to patient recruitment and retention. Boston, MA: Thomson CenterWatch.
Bach, P. B., Cramer, L. D., Warren, J. L., & Begg, C. B. (1999). Racial differences in the treatment of early-stage lung cancer. The New England Journal of Medicine, 341(16), 1198–1205. doi:10.1056/NEJM199910143411606.
Bandura, A. (1986). Social foundations of thought and action. Englewood Cliffs, NJ: Prentice Hall.
Cargill, V. A., & Stone, V. E. (2005). HIV/AIDS: A minority health issue. The Medical Clinics of North America, 89(4), 895–912. doi:10.1016/j.mcna.2005.03.005.
Centers for Disease Control and Prevention. (2005). Viral hepatitis, STD and TB prevention HIV/AIDS among African-American. Retrieved June 15, 2007, from http://www.cdc.gov/hiv/topics/aa/resources/factsheets/aa.htm.
Centers for Disease Control and Prevention. (2006a). HIV/AIDS among Hispanics. Retrieved April 15, 2008, from http://www.cdc.gov/hiv/hispanics/resources/factsheets/hispanic.htm.
Centers for Disease Control and Prevention. (2006b). Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2004. MMWR, 55(5), 121–125.
Cole, S. R., & Ananth, C. V. (2001). Regression models for unconstrained, partially or fully constrained continuation odds ratios. International Journal of Epidemiology, 30(6), 1379–1382. doi:10.1093/ije/30.6.1379.
Ding, E. L., Powe, N. R., Manson, J. E., Sherber, N. S., & Braunstein, J. B. (2007). Sex differences in perceived risks, distrust, and willingness to participate in clinical trials. A randomized study of cardiovascular prevention trials. Archives of Internal Medicine, 167(9), 905–912. doi:10.1001/archinte.167.9.905.
Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R. H., Watters, J., Andersen, M., et al. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392.
El-Sadr, W., & Capps, L. (1992). The challenge of minority recruitment in clinical trials for AIDS. Journal of the American Medical Association, 267(7), 954–957. doi:10.1001/jama.267.7.954.
Gandhi, M., Ameli, N., Bacchetti, P., Sharp, G. B., French, A. L., Young, M., et al. (2005). Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS (London, England), 19(16), 1885–1896. doi:10.1097/01.aids.0000189866.67182.f7.
Gifford, A. L., Cunningham, W. E., Heslin, K. C., Andersen, R. M., Nakazono, T., Lieu, D. K., et al. (2002). Participation in research and access to experimental treatments by HIV-infected patients. The New England Journal of Medicine, 346(18), 1373–1382. doi:10.1056/NEJMsa011565.
Gwadz, M. V., Leonard, N. R., Nakagawa, A., Cylar, K., Finkelstein, M., Herzog, N., et al. (2006). Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds. AIDS Care, 18(7), 786–794. doi:10.1080/09540120500428952.
Hankins, C., Lapointe, N., & Walmsley., S. (1998). Participation in clinical trials among women living with HIV in Canada. Canadian Medical Association, 159(11), 1359–1365.
Harrell, F. E., Margolis, P. A., Gove, S., Mason, K. E., Mulholland, E. K., Lehmann, D., et al. (1998). Development of a clinical prediction model for an ordinal outcome: The World Health Organization multicentre study of clinical signs and etiological agents of pneumonia, sepsis and meningitis in young infants. WHO/ARI Young Infant Multicentre Study Group. Statistics in Medicine, 17(8), 909–944. doi:10.1002/(SICI)1097-0258(19980430)17:8≤909::AID-SIM753≥3.0.CO;2-O.
Harris Interactive. (2000). Cancer clinical trials: Opportunities for increasing enrollment (study no. 11799). Harris Interactive, Inc.: New York.
Killien, M., Bigby, J. A., Champion, V., Fernandez-Repollet, E., Jackson, R. D., Kagawa-Singer M., et al. (2000). Involving minority and underrepresented women in clinical trials: The National Centers of Excellence in Women's Health. Journal of Women's Health & Gender-Based Medicine, 9(10), 1061–1070.
King, T. E., Jr. (2002). Participation in research and access to experimental treatments by HIV-infected patients. The New England Journal of Medicine, 346(18), 1400–1402. doi:10.1056/NEJM200205023461812.
King, W. D., Defreitas, D., Smith, K., Andersen, J., Perry, L. P., Adeyemi, T., et al. (2007). Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: A descriptive study. AIDS Patient Care and STDs, 21(8), 551–563. doi:10.1089/apc.2006.0173.
Lynn, L. A. (1997). AIDS clinical trials: Is there access for all? Journal of General Internal Medicine, 12(3), 198–199.
Marshak, A., Costantini, G., Middleton, S., Barnett, S., Garmon, D., Gwadz, M., Leonard, N., Nakagawa, A., Mildvan, D., & Project ACT Collaborative Research Team. (2007). Screening for AIDS clinical trials in the project ACT cohort of racial/ethnic minorities and women in New York City: Substantial interest but low eligibility. Abstract published in CD-ROM. IAS conference on hiv pathogenesis, treatment and prevention, Sydney, Australia.
Merigan, T. C. (1990). You can teach an old dog new tricks: How AIDS trials are pioneering new strategies. The New England Journal of Medicine, 323(19), 1341–1343.
Miller, W., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford.
Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., & Levine, D. M. (1989). Prevalence, detection, and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association, 261(3), 403–407. doi:10.1001/jama.261.3.403.
National Institute of Allergy and Infectious Diseases. (2005). HIV infection in minority populations. Retrieved April 5, 2008, from http://www.niaid.nih.gov/factsheets/Minor.htm.
National Institute on Drug Abuse. (1991). Risk behavior assessment. Bethesda, MD: Community Research Branch, National Institute on Drug Abuse.
Nova Research Company. (2001). Questionnaire Development System (version 2) [computer software]. Bethesda, MD: Nova Research Company.
Parada, J. (2000). The changing face of AIDS. Minority Health Today, 1(5), 9–17.
RAND Corporation. (1995). HIV cost and services utilization study (HCSUS) baseline questionnaire. Santa Monica, CA: RAND.
Sengupta, S., Strauss, R. P., DeVellis, R., Quinn, S. C., DeVellis, B., & Ware, W. B. (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes, 24(3), 275–284.
Shapiro, M., Morton, S., McCaffrey, D., Senterfitt, J., Fleishman, J., Perlman, J., et al. (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281(24), 2305–2315. doi:10.1001/jama.281.24.2305.
Steele, C. B., Richmond-Reese, V., & Lomax, S. (2006). Racial and ethnic disparities in HIV/AIDS, sexually transmitted diseases, and tuberculosis among women. Journal of Women’s Health, 15(2), 116–122. doi:10.1089/jwh.2006.15.116.
Sullivan, P. S., McNaghten, A. D., Begley, E., Hutchinson, A., & Cargill, V. A. (2007). Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines. Journal of the National Medical Association, 99(3), 242–250.
UyBico, S. J., Pavel, S., & Gross, C. P. (2007). Recruiting vulnerable populations into research: A systematic review of recruitment interventions. Journal of General Internal Medicine, 22(6), 852–863. doi:10.1007/s11606-007-0126-3.
Wendler, D., Kington, R., Madans, J., Van Wye, G., Christ-Schmidt, H., et al. (2006). Are racial and ethnic minorities less willing to participate in health research? PLoS Medicine, 3(2), 0201–0210.
Wu, A., Hays, R., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6(6), 531–554. doi:10.1023/A:1018460132567.
Wynia, M. K., & Gamble, V. N. (2006). Mistrust among minorities and the trustworthiness of medicine. PLoS Medicine, 3(5), 0701–0702.
Acknowledgments
We would like to thank the women and men who participated in this study and the members of the Project ACT Collaborative Study Team. In addition to the paper’s coauthors, the Project ACT Collaborative Study team included: Scott Barnett, Gwen Costantini, Nancy Cotto-Laboy, Rebecca de Guzman, Anthony Diggs, Mindy Finkelstein, Don Garmon, Emily Hardcastle, Sondra Middleton, Kamala Mantha, Aman Nakagawa, Carolina Oteiza, Amanda Ritchie, Maya Tharaken, and Darrell P. Wheeler, PhD, MPH, Associate Dean for Research and Associate Professor, Hunter College School of Social Work. We also wish to thank the staff at the Beth Israel Clinical Trials Unit; the staff at Housing Works, including Patrick Dolby, Duane Ebesu, and Charles King, the President and CEO of Housing Works; the staff at AIDS Service Center NYC; Jonathan M. Kagan, Ph.D., Associate Director, Division of Clinical Research, NIAID/NIH; the staff of the Center for Drug Use and HIV Research at NDRI, including Sherry Deren, Ph.D. (Director). This study was supported by National Institutes of Health Grant # 1U01 46370 to tenth author (DM). Project ACT is dedicated to the memory of Keith Cylar (1958–2004). Mr. Cylar was the Co-founder and Co-CEO of Housing Works, and a Site Principal Investigator for Project ACT.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Keith Cylar—deceased.
Rights and permissions
About this article
Cite this article
Gwadz, M.V., Cylar, K., Leonard, N.R. et al. An Exploratory Behavioral Intervention Trial to Improve Rates of Screening for AIDS Clinical Trials Among Racial/Ethnic Minority and Female Persons Living with HIV/AIDS. AIDS Behav 14, 639–648 (2010). https://doi.org/10.1007/s10461-009-9539-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-009-9539-9